|
ATE256699T1
(de)
*
|
1997-05-30 |
2004-01-15 |
Celltech Therapeutics Ltd |
Entzündungshemmende tyrosin-derivate
|
|
US6291453B1
(en)
|
1997-07-31 |
2001-09-18 |
Athena Neurosciences, Inc. |
4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6559127B1
(en)
|
1997-07-31 |
2003-05-06 |
Athena Neurosciences, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6489300B1
(en)
|
1997-07-31 |
2002-12-03 |
Eugene D. Thorsett |
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6492421B1
(en)
|
1997-07-31 |
2002-12-10 |
Athena Neurosciences, Inc. |
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US7030114B1
(en)
|
1997-07-31 |
2006-04-18 |
Elan Pharmaceuticals, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6423688B1
(en)
|
1997-07-31 |
2002-07-23 |
Athena Neurosciences, Inc. |
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6939855B2
(en)
|
1997-07-31 |
2005-09-06 |
Elan Pharmaceuticals, Inc. |
Anti-inflammatory compositions and method
|
|
US6583139B1
(en)
|
1997-07-31 |
2003-06-24 |
Eugene D. Thorsett |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6362341B1
(en)
|
1997-07-31 |
2002-03-26 |
Athena Neurosciences, Inc. |
Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
DE19741235A1
(de)
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
DE19741873A1
(de)
*
|
1997-09-23 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
CN1327443A
(zh)
*
|
1997-10-31 |
2001-12-19 |
艾文蒂斯药品有限公司 |
取代的酰苯胺化合物
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
DE19751251A1
(de)
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
ES2221227T3
(es)
*
|
1997-11-24 |
2004-12-16 |
MERCK & CO., INC. |
Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular.
|
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
|
US6407065B1
(en)
|
1998-01-23 |
2002-06-18 |
Novartis Ag |
VLA-4 antagonists
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
GB9805655D0
(en)
|
1998-03-16 |
1998-05-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6521626B1
(en)
|
1998-03-24 |
2003-02-18 |
Celltech R&D Limited |
Thiocarboxamide derivatives
|
|
CN1305473A
(zh)
|
1998-04-16 |
2001-07-25 |
得克萨斯生物技术公司 |
抑制整联蛋白与其受体结合的n,n－二取代的酰胺
|
|
DE19821483A1
(de)
|
1998-05-14 |
1999-11-18 |
Hoechst Marion Roussel De Gmbh |
Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
YU75500A
(sh)
*
|
1998-05-28 |
2002-12-10 |
Biogen Inc. |
NOVI VLA-4 INHIBITORI oMePUPA-V
|
|
GB9811969D0
(en)
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9814414D0
(en)
|
1998-07-03 |
1998-09-02 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
AU1915399A
(en)
*
|
1998-07-10 |
2000-02-01 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
|
GB9916374D0
(en)
|
1998-07-23 |
1999-09-15 |
Zeneca Ltd |
Chemical compounds
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9821222D0
(en)
|
1998-09-30 |
1998-11-25 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9825652D0
(en)
|
1998-11-23 |
1999-01-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9826174D0
(en)
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6407066B1
(en)
|
1999-01-26 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
GB9909409D0
(en)
*
|
1999-04-24 |
1999-06-23 |
Zeneca Ltd |
Chemical compounds
|
|
JP4707240B2
(ja)
*
|
1999-05-05 |
2011-06-22 |
アベンティス・フアーマ・リミテッド |
細胞接着調節剤としての尿素
|
|
US6723711B2
(en)
|
1999-05-07 |
2004-04-20 |
Texas Biotechnology Corporation |
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
|
CN100360499C
(zh)
*
|
1999-05-07 |
2008-01-09 |
得克萨斯生物技术公司 |
抑制整联蛋白与其受体结合的丙酸衍生物
|
|
US6972296B2
(en)
|
1999-05-07 |
2005-12-06 |
Encysive Pharmaceuticals Inc. |
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
|
JP3620577B2
(ja)
*
|
1999-05-14 |
2005-02-16 |
栗田工業株式会社 |
超純水製造システムの洗浄方法
|
|
DE19922462A1
(de)
|
1999-05-17 |
2000-11-23 |
Aventis Pharma Gmbh |
Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
US6518283B1
(en)
|
1999-05-28 |
2003-02-11 |
Celltech R&D Limited |
Squaric acid derivatives
|
|
US6756378B2
(en)
|
1999-06-30 |
2004-06-29 |
Pharmacopeia Drug Discovery, Inc. |
VLA-4 inhibitor compounds
|
|
AU5826100A
(en)
*
|
1999-07-13 |
2001-01-30 |
F. Hoffmann-La Roche Ag |
Benzazepinones and quinazolines
|
|
EE200200070A
(et)
|
1999-08-13 |
2003-04-15 |
Biogen, Inc. |
Raku adhesiooni inhibiitorid
|
|
ES2263485T3
(es)
*
|
1999-09-14 |
2006-12-16 |
Biogen Idec Ma Inc. |
Terapia para insuficiencia renal cronica utilizando uno o mas angtagonistas de integrinas.
|
|
SI1214091T1
(sl)
*
|
1999-09-14 |
2006-10-31 |
Biogen Idec Inc |
Terapija za kronicno ledvicno odpoved z uporabo enega ali vec integrinskih antagonistov
|
|
US6534513B1
(en)
|
1999-09-29 |
2003-03-18 |
Celltech R&D Limited |
Phenylalkanoic acid derivatives
|
|
WO2001042192A2
(en)
*
|
1999-12-07 |
2001-06-14 |
Novartis Ag |
Vla-4 integrin antagonists
|
|
US6455539B2
(en)
|
1999-12-23 |
2002-09-24 |
Celltech R&D Limited |
Squaric acid derivates
|
|
WO2001051487A1
(en)
|
1999-12-28 |
2001-07-19 |
Pfizer Products Inc. |
Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
|
|
GB0001348D0
(en)
*
|
2000-01-21 |
2000-03-08 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
DE10006453A1
(de)
*
|
2000-02-14 |
2001-08-16 |
Bayer Ag |
Piperidylcarbonsäuren als Integrinantagonisten
|
|
ATE375330T1
(de)
|
2000-04-17 |
2007-10-15 |
Ucb Pharma Sa |
Enamin-derivate als zell-adhäsionsmoleküle
|
|
GB0011817D0
(en)
*
|
2000-05-16 |
2000-07-05 |
Pharmacia & Upjohn Spa |
Antagonists of integrin receptors
|
|
US6403608B1
(en)
|
2000-05-30 |
2002-06-11 |
Celltech R&D, Ltd. |
3-Substituted isoquinolin-1-yl derivatives
|
|
US6545013B2
(en)
|
2000-05-30 |
2003-04-08 |
Celltech R&D Limited |
2,7-naphthyridine derivatives
|
|
US7065453B1
(en)
|
2000-06-15 |
2006-06-20 |
Accelrys Software, Inc. |
Molecular docking technique for screening of combinatorial libraries
|
|
CA2413418A1
(en)
|
2000-06-21 |
2001-12-27 |
Joseph B. Santella |
Piperidine amides as modulators of chemokine receptor activity
|
|
JP2004502762A
(ja)
|
2000-07-07 |
2004-01-29 |
セルテック アール アンド ディ リミテッド |
二環性ヘテロ芳香環を含有するインテグリンアンタゴニストとしてのスクエア酸誘導体
|
|
EP1305291A1
(en)
|
2000-08-02 |
2003-05-02 |
Celltech R&D Limited |
3-substituted isoquinolin-1-yl derivatives
|
|
GB2369357A
(en)
*
|
2000-10-09 |
2002-05-29 |
Bayer Ag |
Aliphatic, cyclic amino carboxylic acids as integrin antagonists
|
|
CN1592746A
(zh)
|
2000-11-28 |
2005-03-09 |
杰南技术公司 |
Lfa－1拮抗剂化合物
|
|
US7157487B2
(en)
*
|
2000-12-28 |
2007-01-02 |
Daiichi Pharmaceutical Co., Ltd. |
Vla-4 inhibitors
|
|
ES2200617B1
(es)
|
2001-01-19 |
2005-05-01 |
Almirall Prodesfarma, S.A. |
Derivados de urea como antagonistas de integrinas alfa 4.
|
|
UA75392C2
(en)
|
2001-02-23 |
2006-04-17 |
Merck & Co Inc |
N-substituted non-aryl heterocyclic antagonists nmda/nr2b
|
|
DE10111877A1
(de)
|
2001-03-10 |
2002-09-12 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
CA2443108A1
(en)
|
2001-04-03 |
2002-10-17 |
Merck & Co. Inc. |
N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
|
|
US7056917B2
(en)
|
2001-04-26 |
2006-06-06 |
Daiichi Pharmaceutical Co., Ltd. |
Drug efflux pump inhibitor
|
|
GB2377933A
(en)
*
|
2001-07-06 |
2003-01-29 |
Bayer Ag |
Succinic acid derivatives useful as integrin antagonists
|
|
DE10137595A1
(de)
|
2001-08-01 |
2003-02-13 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
|
|
KR101051842B1
(ko)
|
2003-07-24 |
2011-07-25 |
다이이찌 세이야꾸 가부시기가이샤 |
시클로헥산카르복실산류
|
|
JPWO2005066124A1
(ja)
*
|
2003-12-26 |
2007-12-20 |
第一三共株式会社 |
ピロリジン誘導体の製造法
|
|
US7196112B2
(en)
|
2004-07-16 |
2007-03-27 |
Biogen Idec Ma Inc. |
Cell adhesion inhibitors
|
|
GB0517292D0
(en)
|
2005-08-24 |
2005-10-05 |
Univ Dundee |
Cell migration modulating compounds
|
|
EP2124996A4
(en)
|
2007-02-20 |
2010-03-24 |
Merrimack Pharmaceuticals Inc |
METHOD FOR TREATING MULTIPLE SCLEROSIS BY ADMINISTERING AN ALPHA FETOPROTEIN COMBINED WITH AN INTEGRINANT AGONIST
|
|
EP2124562B1
(en)
|
2007-03-09 |
2016-04-20 |
Second Genome, Inc. |
Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
|
|
PL2288715T3
(pl)
|
2008-04-11 |
2015-03-31 |
Merrimack Pharmaceuticals Inc |
Łączniki będące albuminą surowicy ludzkiej i ich koniugaty
|
|
US8563690B2
(en)
|
2008-11-03 |
2013-10-22 |
The Board Of Trustees Of The University Of Illinois |
Modulation of platelet aggregation
|
|
PT3202789T
(pt)
|
2010-04-16 |
2020-06-16 |
Biogen Ma Inc |
Anticorpos anti-vla-4
|
|
US20140094512A1
(en)
|
2012-10-02 |
2014-04-03 |
Nikolas Gunkel |
Method of modulating the degree of adipose tissue deposited intramuscularly
|
|
US10875875B2
(en)
|
2017-04-26 |
2020-12-29 |
Aviara Pharmaceuticals, Inc. |
Propionic acid derivatives and methods of use thereof
|
|
WO2019236417A1
(en)
|
2018-06-04 |
2019-12-12 |
Biogen Ma Inc. |
Anti-vla-4 antibodies having reduced effector function
|
|
CN112969687B
(zh)
|
2018-10-30 |
2024-08-23 |
吉利德科学公司 |
作为α4β7整合素抑制剂的喹啉衍生物
|
|
ES2987796T3
(es)
|
2018-10-30 |
2024-11-18 |
Gilead Sciences Inc |
Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
|
|
ES3003232T3
(en)
|
2018-10-30 |
2025-03-10 |
Gilead Sciences Inc |
Compounds for inhibition of alpha4beta7 integrin
|
|
CA3114240C
(en)
|
2018-10-30 |
2023-09-05 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
|
CN114222730B
(zh)
|
2019-08-14 |
2024-09-10 |
吉利德科学公司 |
用于抑制α4β7整合素的化合物
|